Bardia A, Sun S, Thimmiah N, Coates JT, et al. Antibody Drug Conjugate Sacituzumab Govitecan Enables A Sequential TOP1/PARP Inhibitor Cancer Therapy Strategy in Breast Cancer Patients. Clin Cancer Res 2024 May 6. doi: 10.1158/1078-0432.CCR-24-0428.
PMID: 38709212